Keyphrases
Hepatocellular Carcinoma
100%
Ki-67 Expression
100%
Hepatoma Upregulated Protein
100%
Protein Expression
54%
Microvascular Invasion
36%
Multiple Tumors
27%
Post-resection
27%
Multivariate Analysis
18%
Overall Survival
18%
Non-associated
18%
Ki-67
18%
Hepatocellular Carcinoma Tissues
18%
Patient Outcomes
9%
Cell Growth
9%
Cell Proliferation
9%
Protein Activity
9%
Univariate Analysis
9%
Alpha-fetoprotein
9%
Cancer Genes
9%
Immunohistochemistry
9%
Liver Carcinogenesis
9%
Tumor Size
9%
White Blood Cell Count
9%
Young Age
9%
Female Sex
9%
Prognostic Significance
9%
Independent Prognostic Factor
9%
Recurrence-free Survival
9%
Low Platelet Count
9%
Tumor-node-metastasis Stage
9%
Serum Vascular Endothelial Growth Factor
9%
Biochemistry, Genetics and Molecular Biology
Protein Expression
100%
Overall Survival
33%
Multivariate Analysis
33%
Vascular Endothelial Growth Factor
16%
Cell Growth
16%
Carcinogenesis
16%
Cell Proliferation
16%
Tumor-Related Gene
16%
Tumor Volume
16%
Recurrence Free Survival
16%
Platelet Count
16%
Leukocyte Count
16%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Protein Expression
33%
Proteus Syndrome
16%
Multivariate Analysis
11%
Neoplasm
11%
Overall Survival
11%
Leukocyte
5%
Cell Count
5%
Immunohistochemistry
5%
Metastatic Carcinoma
5%
Cell Growth
5%
Cell Proliferation
5%
Vasculotropin
5%
Prognostic Factor
5%
Liver Carcinogenesis
5%
Univariate Analysis
5%
Tumor-Related Gene
5%
Low Platelet Count
5%
Recurrence Free Survival
5%
Fetoprotein
5%
Indocyanine Green
5%
Surgery
5%
Immunology and Microbiology
Protein Expression
100%
Overall Survival
33%
Cell Growth
16%
Cell Proliferation
16%
Vasculotropin
16%
Tumor-Related Gene
16%
Tumor Volume
16%
Recurrence Free Survival
16%
Platelet Count
16%
Leukocyte Count
16%
Neuroscience
Protein Expression
100%
Immunohistochemistry
16%
Cell Proliferation
16%
Leukocyte
16%
Cell Growth
16%
Tumor-Related Gene
16%
Vascular Endothelial Growth Factor
16%
Carcinogenesis
16%
Fetoprotein
16%
Platelet
16%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Multiple Cancer
16%
Neoplasm
11%
Overall Survival
11%
Malignant Neoplasm
5%
Vasculotropin
5%
Liver Carcinogenesis
5%
Indocyanine Green
5%
Recurrence Free Survival
5%
Fetoprotein
5%